Board Diversity Matrix 2022
The following table provides information regarding certain diversity characteristics that the members of the Board of Directors of Quantum BioPharma have authorized us to disclose on their behalf.
Board Diversity Matrix (As of August 8, 2022)
| Country of Principal Executive Offices | Canada |
|---|---|
| Foreign Private Issuer | Yes |
| Disclosure Prohibited under Home Country Law | No |
| Total Number of Directors | 7 |
Part I: Gender Identity
| Female | 0 |
|---|---|
| Male | 7 |
| Non-Binary | 0 |
| Did Not Disclose Gender | 0 |
Part II: Demographic Background
| Underrepresented Individual in Home Country Jurisdiction | 4 |
|---|---|
| LGBTQ+ | 0 |
| Did Not Disclose Demographic Background | 0 |
Investor Relations
Chris Tyson
Executive Vice President
MZ North America
Direct:
949-491-8235
QNTM@mzgroup.us